MARKET

LQDA

LQDA

Liquidia Corporation
NASDAQ
38.85
+0.30
+0.78%
After Hours: 38.37 -0.48 -1.24% 18:54 04/13 EDT
OPEN
38.20
PREV CLOSE
38.55
HIGH
39.01
LOW
37.55
VOLUME
700.70K
TURNOVER
--
52 WEEK HIGH
46.67
52 WEEK LOW
11.85
MARKET CAP
3.42B
P/E (TTM)
-48.5079
1D
5D
1M
3M
1Y
5Y
1D
Liquidia CEO Roger Jeffs disposes of common shares worth $1,002,888.75
PUBT · 8h ago
Liquidia CFO/COO Michael Kaseta sells 133,789 shares for $5,384,439.91
PUBT · 8h ago
Weekly Report: what happened at LQDA last week (0406-0410)?
Weekly Report · 20h ago
Liquidia joins Needham Virtual Healthcare Conference fireside chat update
Reuters · 6d ago
Liquidia Corporation to Participate in Upcoming Investor Conferences
Barchart · 6d ago
Weekly Report: what happened at LQDA last week (0330-0403)?
Weekly Report · 04/06 09:12
Does Liquidia Corporation (LQDA) Have the Potential to Rally 34.47% as Wall Street Analysts Expect?
NASDAQ · 04/03 13:55
Notable Wednesday Option Activity: LQDA, CRK, TH
NASDAQ · 04/01 19:52
More
About LQDA
Liquidia Corporation is a biopharmaceutical company. The Company is focused on the development, manufacture and commercialization of products that address unmet patient needs, with a focus directed towards rare cardiopulmonary diseases, such as pulmonaryarterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The Company operate through its wholly owned operating subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Its proprietary PRINT technology is a particle engineering platform, which enable precise production of uniform drug particles. Its lead product candidate is YUTREPIA for the treatment of PAH and PH-ILD. YUTREPIA is an inhaled dry powder formulation of treprostinil designed with PRINT to improve the therapeutic profile of treprostinil by enhancing deep lung delivery while using a convenient, dry-powder inhaler (DPI) and by achieving higher dose levels than the labeled doses of current inhaled therapies.

Webull offers Liquidia Corp stock information, including NASDAQ: LQDA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LQDA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LQDA stock methods without spending real money on the virtual paper trading platform.